Metformin v/s glibenclamide : for intial therapy of type 2 diabetes mellitus in a tertiary care hospital, a comparative study, for efficacy and tolerability. Int. J. of Res. in Pharmacology &Pharmacotherapeutics [Internet]. 2021 Mar. 30 [cited 2026 Apr. 21];8(1):23-8. Available from: https://www.ijrpp.com/ijrpp/article/view/50